Logo image of ALECR.PA

EUROFINS CEREP-REGR (ALECR.PA) Stock Price, Quote, News and Overview

EPA:ALECR - Euronext Paris - Matif - FR0013256518 - Common Stock - Currency: EUR

17600  -700 (-3.83%)

ALECR.PA Quote, Performance and Key Statistics

EUROFINS CEREP-REGR

EPA:ALECR (8/4/2025, 7:00:00 PM)

17600

-700 (-3.83%)

Sector
GICS SectorHealth Care
GICS IndustryLife Sciences Tools & Services
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryLife Sciences Tools & Services
Statistics
52 Week High29200
52 Week Low4620
Market Cap176.00M
Shares10.00K
Float0
Yearly DividendN/A
Dividend YieldN/A
PE24.28
Fwd PEN/A
Earnings (Next)N/A N/A
IPO03-19 2010-03-19


ALECR.PA short term performance overview.The bars show the price performance of ALECR.PA in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 10 -10 -20

ALECR.PA long term performance overview.The bars show the price performance of ALECR.PA in the last 1, 2 and 3 years. 1 year 2 years 3 years 0 50 100 150

The current stock price of ALECR.PA is 17600 EUR. In the past month the price decreased by -16.19%. In the past year, price increased by 181.6%.

EUROFINS CEREP-REGR / ALECR Daily stock chart

ALECR.PA Competitors/Peers

The largest stocks on the EU markets in the "Life Sciences Tools & Services" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
1TMO.MI THERMO FISHER SCIENTIFIC INC 20.39 147.75B
TN8.DE THERMO FISHER SCIENTIFIC INC 20.79 147.49B
DAP.DE DANAHER CORP 26.27 121.51B
LO3.DE LONZA GROUP AG-REG 35.52 41.08B
56S1.DE SARTORIUS STEDIM BIOTECH 40.51 16.28B
DIM.PA SARTORIUS STEDIM BIOTECH 40.4 16.24B
SRT3.DE SARTORIUS AG-VORZUG 41.61 13.55B
ILU.DE ILLUMINA INC 22.57 12.75B
ERF.PA EUROFINS SCIENTIFIC 20.14 12.11B
ESF0.DE EUROFINS SCIENTIFIC 19.75 11.87B
SRT.DE SARTORIUS AG 34.25 11.16B
QIA.DE QIAGEN N.V. 20.44 8.90B

About ALECR.PA

Company Profile

ALECR logo image Eurofins-Cerep SA engages in the provision of preclinical drug research services. The company is headquartered in Celle-Levescault, Nouvelle-Aquitaine and currently employs 218 full-time employees. The company went IPO on 2010-03-19. The Company, using its BioPrint technology systems that analyzes pharmaceutical drugs on the market, those that have been withdrawn, and those that failed in the development stages, builds up predictive models of the potential of new drugs. These predictions are based on the drugs' chemical structure and their performance in vitro. The firm then offers solutions to the pharmaceutical and biotechnology sectors on reducing time and costs in the early stages of the drug development process. Clients can also gain access to some of the Company's technology by subscribing to BioPrint. The Company’s maximum revenue is generated through Exports accounts.

Company Info

EUROFINS CEREP-REGR

Le Bois l'Eveque

Celle-Levescault NOUVELLE-AQUITAINE FR

Employees: 218

ALECR Company Website

ALECR Investor Relations

Phone: 33549893000

EUROFINS CEREP-REGR / ALECR.PA FAQ

What is the stock price of EUROFINS CEREP-REGR today?

The current stock price of ALECR.PA is 17600 EUR. The price decreased by -3.83% in the last trading session.


What is the ticker symbol for EUROFINS CEREP-REGR stock?

The exchange symbol of EUROFINS CEREP-REGR is ALECR and it is listed on the Euronext Paris - Matif exchange.


On which exchange is ALECR.PA stock listed?

ALECR.PA stock is listed on the Euronext Paris - Matif exchange.


What is EUROFINS CEREP-REGR worth?

EUROFINS CEREP-REGR (ALECR.PA) has a market capitalization of 176.00M EUR. This makes ALECR.PA a Micro Cap stock.


How many employees does EUROFINS CEREP-REGR have?

EUROFINS CEREP-REGR (ALECR.PA) currently has 218 employees.


What are the support and resistance levels for EUROFINS CEREP-REGR (ALECR.PA) stock?

EUROFINS CEREP-REGR (ALECR.PA) has a support level at 16208 and a resistance level at 17714.3. Check the full technical report for a detailed analysis of ALECR.PA support and resistance levels.


Should I buy EUROFINS CEREP-REGR (ALECR.PA) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does EUROFINS CEREP-REGR (ALECR.PA) stock pay dividends?

ALECR.PA does not pay a dividend.


What is the Price/Earnings (PE) ratio of EUROFINS CEREP-REGR (ALECR.PA)?

The PE ratio for EUROFINS CEREP-REGR (ALECR.PA) is 24.28. This is based on the reported non-GAAP earnings per share of 725 and the current share price of 17600 EUR. Check the full fundamental report for a full analysis of the valuation metrics for ALECR.PA.


ALECR.PA Technical Analysis

ChartMill assigns a technical rating of 4 / 10 to ALECR.PA. When comparing the yearly performance of all stocks, ALECR.PA is one of the better performing stocks in the market, outperforming 97.89% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

ALECR.PA Fundamental Analysis

ChartMill assigns a fundamental rating of 5 / 10 to ALECR.PA. ALECR.PA has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

ALECR.PA Financial Highlights

Over the last trailing twelve months ALECR.PA reported a non-GAAP Earnings per Share(EPS) of 725. The EPS decreased by -21.28% compared to the year before.


Industry RankSector Rank
PM (TTM) 16.86%
ROA 9.29%
ROE 10.82%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%-12.19%
Sales Q2Q%-7.12%
EPS 1Y (TTM)-21.28%
Revenue 1Y (TTM)-6.85%

ALECR.PA Ownership and Analysts


Ownership
Inst OwnersN/A
Ins OwnersN/A
Short Float %N/A
Short RatioN/A
Analysts
AnalystsN/A
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A